GENETICS IN MEDICINE, published by Elsevier Science Inc, stands as a premier journal in the realms of clinical genetics and medicine. With an impressive impact factor and ranked #3 out of 99 in the category of Genetics (clinical), alongside a 97th percentile ranking in the Scopus database, this journal is recognized for its outstanding contribution to the field. Established in 1998, it aims to disseminate innovative research and clinical advancements bridging genetics and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. Although not an open-access journal, GENETICS IN MEDICINE provides valuable insights into genetics that drive the future of personalized medicine and patient care. With a commitment to excellence, the journal continuously explores the evolving landscape of genetic research to foster the understanding and application of genetic principles in medical contexts.

Genome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.

HUMAN GENETICS, published by SPRINGER, stands as a cornerstone journal in the field of genetics, offering a wealth of research insights since its inception in 1964. Hailing from Germany, this esteemed journal boasts an impressive Q1 ranking in both Genetics and Clinical Genetics, marking it among the top quartile of journals in these categories for 2023. With a notable Scopus rank of #7 in Clinical Genetics and a percentile ranking of 93, HUMAN GENETICS attracts significant attention from researchers and professionals dedicated to advancing our understanding of genetic influences on human health and disease. Although it does not currently offer Open Access options, the journal provides a critical platform for scholarly communication, aimed at disseminating groundbreaking findings in genetics and biotechnology. As the field evolves, HUMAN GENETICS continues to play an instrumental role in bridging the gap between laboratory research and clinical application, making it an essential resource for students and seasoned researchers alike.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

Human Genetics and Genomics Advances is a premier academic journal published by Elsevier, dedicated to the field of human genetics and genomic medicine. With an ISSN of 2666-2477, this journal has quickly established itself as a leading platform for disseminating cutting-edge research from its inception in 2020. Featured prominently in Q1 categories for both Clinical Genetics and Molecular Medicine as of 2023, it ranks favorably among its peers, reflected in its Scopus rankings. The journal not only offers valuable insights into the latest advancements and applications in genetics but also facilitates open dialogue among researchers, clinicians, and students. As an open access publication, it ensures that groundbreaking findings in genetics are readily accessible to a global audience, promoting knowledge sharing and collaboration. Human Genetics and Genomics Advances continues to be instrumental in moving the field forward, providing a vital resource for those at the forefront of genetic and genomic research.

PLoS Genetics, published by the PUBLIC LIBRARY SCIENCE, is a leading open-access journal dedicated to advancing the field of genetics, molecular biology, and related disciplines. With its ISSN of 1553-7404, this esteemed journal has been offering unrestricted access to its content since 2005, fostering a global community of researchers, professionals, and students. Situated in the United States, its contributions can be found at 1160 Battery Street, Ste 100, San Francisco, CA 94111. As of 2023, PLoS Genetics proudly holds a Q1 ranking in multiple categories including Cancer Research, Ecology, Evolution, Behavior and Systematics, Genetics, and Molecular Biology, underscoring its impact in these vital scientific areas. The journal's commitment to disseminating high-quality research is reflected in its impressive Scopus rankings, with notable positions in various fields of study, ensuring that it remains a crucial resource for cutting-edge research and innovation. By providing an open-access platform, PLoS Genetics not only enhances the visibility of genetic research but also encourages collaborations and the sharing of knowledge that can lead to significant breakthroughs in science.

Evolutionary Bioinformatics, published by SAGE Publications Ltd, is a pioneering open-access journal established in 2005, dedicated to advancing the field of evolutionary biology through innovative computational techniques and bioinformatics. With an ISSN of 1176-9343, it serves as a critical platform for researchers, professionals, and students to disseminate impactful findings and foster collaboration across disciplines. The journal spans a broad scope, contributing significantly to the areas of Ecology, Evolution, Behavior and Systematics, and Genetics, as evidenced by its respectable Scopus rankings and quartile placements in 2023. With a commitment to providing comprehensive, peer-reviewed research articles and tools for sharing knowledge, Evolutionary Bioinformatics plays an essential role in shaping the future of evolutionary studies and bioinformatics. Readers and contributors alike are encouraged to engage with cutting-edge research that pushes the boundaries of understanding in this dynamic field.

ANIMAL GENETICS, published by WILEY, is a leading journal in the fields of Animal Science and Zoology, with a commendable Q1 classification for 2023, reflecting its critical role in advancing research and knowledge in animal genetics. Established in 1986, this journal has become a cornerstone for professionals, researchers, and students alike, providing a platform for innovative research that explores the genetic underpinnings of animal biology. With an ISSN of 0268-9146 and an E-ISSN of 1365-2052, it boasts a significant impact in both agricultural and biological sciences, as indicated by its ranking of #74 out of 490 in its category on Scopus, positioning it in the 85th percentile for Animal Science and Zoology. Readers can access high-quality, peer-reviewed articles that not only illuminate current advancements but also foster future research directions. While currently not an open access journal, ANIMAL GENETICS remains vital for anyone engaged in the exploration of genetics and its applications in medicine and beyond, with a continual commitment to publishing findings that shape the future of animal breeding, conservation, and genetics research.

BMC Medical Genomics is a prominent peer-reviewed open-access journal published by BMC, specializing in the integration of genomics within the medical field. Since its inception in 2008, this journal has positioned itself at the forefront of genomic research, contributing to significant advancements in understanding the genetic underpinnings of diseases. With an impressive impact factor reflective of its rigorous scholarship, BMC Medical Genomics holds a prestigious Q2 ranking in the field of Genetics and a Q3 ranking in Clinical Genetics, showcasing its relevance and influence in shaping contemporary research paradigms. The journal is recognized in various databases, including Scopus, where it ranks 58th in Clinical Genetics, emphasizing its importance within the medical community. By facilitating open access to its comprehensive articles, BMC Medical Genomics aims to foster collaboration among researchers, healthcare professionals, and students, thereby enhancing the collective understanding of genomics in medicine. Its commitment to delivering high-quality research makes it an essential resource for those immersed in this dynamic and rapidly evolving field.

International Journal of Genomics is a pivotal open-access publication under the esteemed HINDAWI LTD, dedicated to advancing the fields of genomics, biochemistry, genetics, and molecular biology. Established in 2013, this journal aims to disseminate innovative research findings and foster scholarly dialogue among researchers, professionals, and students alike. With a robust Impact Factor reflective of its commitment to quality, the journal has achieved a Q3 ranking in Biochemistry, Genetics, and Molecular Biology, as well as notable placements in Pharmaceutical Science, indicating its broad relevance and influence in these interconnected fields. The journal is indexed in esteemed databases, ensuring high visibility and accessibility for published works. As an open-access journal, it prioritizes the sharing of knowledge across borders, facilitating greater collaboration and advancement in genomic research globally. Join the academic community in exploring the vast potential of genomics through the International Journal of Genomics, based in Egypt, and reaching audiences worldwide from its London office.